Page 3 - Kirk Huntsman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vivos Therapeutics highlights path to cash flow positivity after FDA clearance

Vivos Therapeutics highlights path to cash flow positivity after FDA clearance
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

United statesEast north africaKirk huntsmanVivos institute in denverDrug administrationVivos therapeuticsVivos integrated providerVivos instituteDemand orthodontistMiddle east north africaVivo chairmanChief executive officer

Vivos Therapeutics, Inc (NASDAQ:VVOS) Q4 2023 Earnings Call Transcript

Vivos Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-3.05 EPS, expectations were $-1.9.

United statesScott henryKirk huntsmanJulie gannonVivos therapeutics incDrug administrationExchange commissionVivos instituteVivos therapeuticsCall transcript marchVivos therapeutics fourth quarterFull yearInvestor relationsVivo investor relations officerVivo chairmanChief executive officer

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited arab emiratesEast north africaKirk huntsmanJulie gannonSecurities exchangeDrug administrationEnvista holdings corporationAirway repositioningVivos institute in denverVivos therapeutics incExchange commissionPositive business momentumSales pipeline growth followingVivo proprietary oral medical devicesTreat severe obstructive sleep

Vivos: Market Developments to Boost for Oral Appliance Therapy

Vivos highlighted market developments that it says are creating opportunities to widen its funnel of users of its oral appliance therapies.

Kirk huntsmanPhilips respironicsDrug administrationVivos therapeutics incUnited healthcare

Vivos Therapeutics sees opportunities for its FDA-approved oral sleep apnea treatment

Vivos Therapeutics sees opportunities for its FDA-approved oral sleep apnea treatment
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Philips respironicPhilips respironicsKirk huntsmanDrug administrationUnitedhealth group incVivos therapeutics